Green Cash Money

IDO Security, Inc. engages in the design, development, and marketing of technology based security systems for the homeland security and loss prevention markets. Its products are used in security screening procedures and are designed to detect ferrous and non-ferrous metallic objects concealed on or in shoes, ankles, and feet through the use of electro-magnetic fields. The company offers MagShoe, which is used to detect metallic items during security screenings, as well as at security checkpoints in venues, such as schools, prisons, commercial aviation and maritime facilities, rail transportation, shopping centers/places of entertainment, business facilities bus and train stations, border crossings, government institutions/buildings, critical infrastructure, and defense facilities. IDO Security was founded in 2002 and is based in New York, New York.

IDOI at 9:39 AM 7/9/2009:  Running up:

JayHawk Energy, Inc. and its subsidiary, JayHawk Gas Transportation Corporation, engage in the acquisition, exploration, development, production, and sale of natural gas, crude oil, and natural gas liquids primarily from conventional reservoirs within North America. It owns interests in the Uniontown project covering mineral lease of approximately 35,000 gross acres in Kansas; Girard project covering 44,216 leased acres in Kansas; and Candak project, which includes 5 producing wells, as well as oil, gas, and mineral rights in a 15,500-acre land. The company also transports its gas in Kansas through a pipeline. JayHawk Energy, Inc. was formerly known as Bella Trading Company, Inc. and changed its name to JayHawk Energy, Inc. in June 2007. JayHawk Energy, Inc. was founded in 2004 and is based in Post Falls, Idaho.

JYHW at 9:48 AM 6/11/2009:  Running up briskly

Bullion Monarch Mining, Inc. engages in the acquisition, exploration, leasing, joint venturing, and sale of mining properties in the western United States. It holds royalty interest in the north pipeline placer mine located in Lander County, Nevada, which is operated by Nevada Rae Gold, Inc. The company also has royalty interests in the Maggie Creek, and the Leeville/East Ore Mine properties located in Eureka County, Nevada. In addition, it develops a technology that covers a process for the extraction of oil from oil shale. The company was incorporated in 1948 and is based in Orem, Utah.

BULM at 10:39 AM 6/3/2009:  Running up briskly:

PureSpectrum, Inc. researches and develops proprietary products and technologies used in various forms of lighting products. It develops an energy saving technology, which is used in various florescent, compact fluorescent, and high intensity discharge lighting products. The company also owns various patents, pending patents, and provisional patents relating to ballast technology; and licenses its technology to lighting products manufacturers to incorporate the technology into new and existing products. PureSpectrum is headquartered in Savannah, Georgia.

PSPM at 10:36 AM 6/1/2009:  Running up briskly

Biovest International, Inc., a biotechnology company, develops therapeutic anti-cancer vaccine for the treatment of low-grade Follicular Lymphoma in the United States. It develops BiovaxID, a Phase III clinical trial product, which is an injectable patient-specific vaccine to treat the follicular form of non-Hodgkin’s lymphoma. The company develops, manufactures, and markets cell culture systems, equipment, and consumable parts to pharmaceutical, diagnostic, and biotechnology companies, as well as to research institutions worldwide. Biovest International also produces mammalian and insect cells, monoclonal antibodies, recombinant and secreted proteins, and other cell culture products using hollow fiber perfusion. It is also developing an automated cell culture instrument, AutovaxID that enables production of personalized cell-based treatments. In addition, the company sells hollow fiber bioreactors, cultureware, tubing sets, and other disposable products and supplies. Further, Biovest International engages in the production and contract manufacture of biologic drugs and cell production for research institutions. Its customers include biopharmaceutical and biotech companies, medical schools, universities, research facilities, hospitals, and public and private laboratories. The company was incorporated in 1981 as Endotronics, Inc. and changed its name to Cellex Biosciences, Inc. in 1993. Further, it changed its name to Biovest International, Inc. in 2001. The company is based in Worcester, Massachusetts. Biovest International, Inc. is a subsidiary of Accentia Biopharmaceuticals, Inc. On November 10, 2008, Biovest International Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, Tampa, in joint administration with Accentia Biopharmaceuticals, Inc.

BVTI at 9:51 AM 5/29/2009:  Running up briskly

Genta Incorporated operates as a biopharmaceutical company with a diversified product portfolio that is focused on delivering products for the treatment of patients with cancer. Its research portfolio consists of two programs, DNA/RNA Medicines and Small Molecules. The company’s lead compound from its DNA/RNA Medicines program is Genasense (oblimersen sodium) injection that is designed to block the production of a protein, known as Bcl-2, which is a fundamental cause of the inherent resistance of cancer cells to anticancer treatments, such as chemotherapy, radiation, and monoclonal antibodies. Genta Incorporated is recruiting patients to the AGENDA Trial, a global Phase III trial of Genasense in patients with advanced melanoma. Its lead drug in its Small Molecule program is Ganite (gallium nitrate injection), which is marketed in the United States for the treatment of symptomatic patients with cancer-related hypercalcemia that is resistant to hydration. The company also develops G4544, an oral formulation of the active ingredient in Ganite, which entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. In addition, it is developing tesetaxel, an orally absorbed, semi-synthetic taxane that is in the same drug class as paclitaxel and docetaxel. The company was founded in 1988 and is based in Berkeley Heights, New Jersey.

GNTA at 10:01 AM 5/26/2009:  Running up quickly

Electronic Game Card, Inc., through its subsidiaries, engages in the development, marketing, sale, and distribution of recreational electronic software for lottery, casino, sales promotion, and incentive markets worldwide. The company markets its products under the EGC Electronic GameCard name, which is a credit card-sized pocket game consisting of a random number generator. Its product is also equipped with a microchip and liquid crystal display screen showing numbers or icons. The company was founded in 1981 and is based in Carson City, Nevada.

EGMI at 10:34 AM 5/19/2009: Running up